Effect of Time Since Heart Failure Diagnosis or Hospitalization on the Cost-Effectiveness of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction.

IF 8.2 2区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

Journal of Cardiac Failure Pub Date : 2025-08-05 DOI:10.1016/j.cardfail.2025.06.014

Ankeet S Bhatt, Rudolf A DE Boer, David Booth, Jason A Davis, Toru Kondo, Pardeep Jhund, Jieling Chen

引用次数: 0

查看原文本刊更多论文

心衰诊断或住院时间对达格列净治疗射血分数轻度降低或保留的心衰患者的成本-效果的影响

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Cardiac Failure 医学-心血管系统

CiteScore

7.80

自引率

8.30%

发文量

653

审稿时长

21 days

期刊介绍： Journal of Cardiac Failure publishes original, peer-reviewed communications of scientific excellence and review articles on clinical research, basic human studies, animal studies, and bench research with potential clinical applications to heart failure - pathogenesis, etiology, epidemiology, pathophysiological mechanisms, assessment, prevention, and treatment.